for patients who undergo curative resection. 6 Unfortunately, To render hepatectomy feasible in patients with an the percentage of patients likely to benefit from hepatic resecinitially deficient volume of the future remnant liver tion ranges from 5% 7 to 10% 8 in patients with adenocarci-(FRL), we
β¦ LIBER β¦
Extension of surgical indications for hepatocellular carcinoma by portal vein embolization
β Scribed by Kwang Choon Lee; Hiroaki Kinoshita; Kazuhiro Hirohashi; Shoji Kubo; Ryutaro Iwasa
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 730 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Preoperative portal vein embolization fo
β
T de Baere; A Roche; D Elias; P Lasser; C Lagrange; V Bousson
π
Article
π
1996
π
John Wiley and Sons
π
English
β 627 KB
Percutaneous Transumbilical Portal Vein
β
Soo Chin Kim; Hyo-Cheol Kim; Jin Wook Chung; Hwan Jun Jae; Jae Hyung Park
π
Article
π
2010
π
Springer
π
English
β 242 KB
Treatment of hepatocellular carcinoma by
β
Charles J. Lightdale
π
Article
π
1987
π
John Wiley and Sons
π
English
β 284 KB
Transcatheter arterial embolization (TAE) is an effective means of treatment in primary hepatocellular carcinoma (HCC). However, in many cases of HCC the tumor recurs after treatment. In an attempt to obtain complete tumor necrosis, the authors studied the clinical and histologic effect of simultane
Transient portal vein thrombosis caused
β
Rong Qin Zheng; Masatoshi Kudo; Kanae Inui; Yoichiro Suetomi; Yasunori Minami; H
π
Article
π
2003
π
Springer Japan
π
English
β 190 KB
Three-dimensional conformal radiotherapy
β
Dae Yong Kim; Won Park; Do Hoon Lim; Joon Hyoek Lee; Byung Chul Yoo; Seung Woon
π
Article
π
2005
π
John Wiley and Sons
π
English
β 169 KB
Re: βThe Efficacy of Adjuvant Transarter
β
Stephen J Wigmore
π
Article
π
2006
π
Springer
π
English
β 35 KB